Literature DB >> 17478437

Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome.

Christoph U Correll1, Julie B Penzner, Anne M Frederickson, Jessica J Richter, Andrea M Auther, Christopher W Smith, John M Kane, Barbara A Cornblatt.   

Abstract

OBJECTIVE: The presence and specificity of a bipolar prodrome remains questioned. We aimed to characterize the prodrome prior to a first psychotic and nonpsychotic mania and to examine the phenotypic proximity to the schizophrenia prodrome.
METHODS: Using a semi-structured interview, the Bipolar Prodrome Symptom Scale-Retrospective, information regarding the mania prodrome was collected from youth with a research diagnosis of bipolar I disorder and onset before 19 years of age, and/or their caregivers. Only newly emerging, at least moderately severe, symptoms were analyzed. Prodromal characteristics were compared between patients with and without subsequent psychotic mania and with published bipolar and schizophrenia prodrome data.
RESULTS: In 52 youth (age at first mania: 13.4 +/- 3.3 years), the prodrome onset was predominantly "insidious" (>1 year, 51.9%) or "subacute" (1-12 months, 44.2%), while "acute" presentations (<1 month, 3.8%) were rare. The prodrome duration was similar in patients with (1.7 +/- 1.8 years, n = 34) and without (1.9 +/- 1.5 years, n = 18) subsequent psychotic mania (P = .70). Attenuated positive symptoms emerging late in the prodrome and increased energy/goal-directed activity were significantly more common in patients with later psychotic mania. Mania and schizophrenia prodrome characteristics overlapped considerably. However, subsyndromal unusual ideas were significantly more likely part of the schizophrenia prodrome, while obsessions/compulsions, suicidality, difficulty thinking/communicating clearly, depressed mood, decreased concentration/memory, tiredness/lack of energy, mood lability, and physical agitation were more likely part of the mania prodrome.
CONCLUSIONS: A lengthy and symptomatic prodrome makes clinical high-risk research a feasible goal for bipolar disorder. The phenotypic overlap with the schizophrenia prodrome necessitates the concurrent study of both illness prodromes.

Entities:  

Mesh:

Year:  2007        PMID: 17478437      PMCID: PMC2526140          DOI: 10.1093/schbul/sbm028

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  69 in total

1.  Can we improve the diagnostic efficiency and predictive power of prodromal symptoms for schizophrenia?

Authors:  P D McGorry; D McKenzie; H J Jackson; F Waddell; C Curry
Journal:  Schizophr Res       Date:  2000-04-07       Impact factor: 4.939

2.  The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies.

Authors:  H Häfner; W an der Heiden
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

3.  Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

Authors:  Peter B Jones; Thomas R E Barnes; Linda Davies; Graham Dunn; Helen Lloyd; Karen P Hayhurst; Robin M Murray; Alison Markwick; Shôn W Lewis
Journal:  Arch Gen Psychiatry       Date:  2006-10

4.  Lithium for prepubertal depressed children with family history predictors of future bipolarity: a double-blind, placebo-controlled study.

Authors:  B Geller; T B Cooper; B Zimerman; J Frazier; M Williams; J Heath; K Warner
Journal:  J Affect Disord       Date:  1998-11       Impact factor: 4.839

5.  Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.

Authors:  Thomas H McGlashan; Robert B Zipursky; Diana Perkins; Jean Addington; Tandy Miller; Scott W Woods; Keith A Hawkins; Ralph E Hoffman; Adrian Preda; Irvin Epstein; Donald Addington; Stacy Lindborg; Quynh Trzaskoma; Mauricio Tohen; Alan Breier
Journal:  Am J Psychiatry       Date:  2006-05       Impact factor: 18.112

Review 6.  Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents.

Authors:  Robert A Kowatch; Eric A Youngstrom; Arman Danielyan; Robert L Findling
Journal:  Bipolar Disord       Date:  2005-12       Impact factor: 6.744

7.  Psychiatric phenomenology of child and adolescent bipolar offspring.

Authors:  K D Chang; H Steiner; T A Ketter
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-04       Impact factor: 8.829

8.  Clinical course of children and adolescents with bipolar spectrum disorders.

Authors:  Boris Birmaher; David Axelson; Michael Strober; Mary Kay Gill; Sylvia Valeri; Laurel Chiappetta; Neal Ryan; Henrietta Leonard; Jeffrey Hunt; Satish Iyengar; Martin Keller
Journal:  Arch Gen Psychiatry       Date:  2006-02

Review 9.  Pharmacological treatment in the early phase of bipolar disorders: what stage are we at?

Authors:  Philippe Conus; Michael Berk; Patrick D McGorry
Journal:  Aust N Z J Psychiatry       Date:  2006-03       Impact factor: 5.744

Review 10.  Early identification and high-risk strategies for bipolar disorder.

Authors:  Christoph U Correll; Julie B Penzner; Todd Lencz; Andrea Auther; Christopher W Smith; Anil K Malhotra; John M Kane; Barbara A Cornblatt
Journal:  Bipolar Disord       Date:  2007-06       Impact factor: 6.744

View more
  48 in total

1.  The empirical status of the ultra high-risk (prodromal) research paradigm.

Authors:  Tyrone D Cannon; Barbara Cornblatt; Patrick McGorry
Journal:  Schizophr Bull       Date:  2007-04-29       Impact factor: 9.306

2.  Correlates, Course, and Outcomes of Increased Energy in Youth with Bipolar Disorder.

Authors:  Elisabeth A Frazier; Jeffrey I Hunt; Heather Hower; Richard N Jones; Boris Birmaher; Michael Strober; Benjamin I Goldstein; Martin B Keller; Tina R Goldstein; Lauren M Weinstock; Daniel P Dickstein; Rasim S Diler; Neal D Ryan; Mary Kay Gill; David Axelson; Shirley Yen
Journal:  J Affect Disord       Date:  2020-04-18       Impact factor: 4.839

Review 3.  Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder.

Authors:  Elena Ivleva; Gunvant Thaker; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2008-05-30       Impact factor: 9.306

Review 4.  The significance of at-risk or prodromal symptoms for bipolar I disorder in children and adolescents.

Authors:  Marta Hauser; Christoph U Correll
Journal:  Can J Psychiatry       Date:  2013-01       Impact factor: 4.356

5.  [Prevention of bipolar disorders].

Authors:  K Leopold; A Pfennig; E Severus; M Bauer
Journal:  Nervenarzt       Date:  2013-11       Impact factor: 1.214

6.  [Early recognition and intervention for bipolar disorders: state of research and perspectives].

Authors:  A Pfennig; C U Correll; K Leopold; G Juckel; M Bauer
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

7.  The Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls.

Authors:  Christoph U Correll; Doreen M Olvet; Andrea M Auther; Marta Hauser; Taishiro Kishimoto; Ricardo E Carrión; Stephanie Snyder; Barbara A Cornblatt
Journal:  Bipolar Disord       Date:  2014-05-08       Impact factor: 6.744

Review 8.  Pediatric bipolar disorder: evidence for prodromal states and early markers.

Authors:  Joan L Luby; Neha Navsaria
Journal:  J Child Psychol Psychiatry       Date:  2010-01-18       Impact factor: 8.982

Review 9.  Diagnosis and treatment in the early illness phase of bipolar disorders.

Authors:  Michael Bauer; Georg Juckel; Christoph U Correll; Karolina Leopold; Andrea Pfennig
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

10.  Anticipating DSM-V: should psychosis risk become a diagnostic class?

Authors:  William T Carpenter
Journal:  Schizophr Bull       Date:  2009-07-24       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.